These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38450928)

  • 21. Bone: Use of bisphosphonates in children-proceed with caution.
    Marini JC
    Nat Rev Endocrinol; 2009 May; 5(5):241-3. PubMed ID: 19444252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates.
    Muratore M; Quarta E; Grimaldi A; Calcagnile F; Quarta L
    Drug Des Devel Ther; 2011; 5():445-54. PubMed ID: 22087064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates for osteoporosis.
    Drug Ther Bull; 2001 Sep; 39(9):68-72. PubMed ID: 11586803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis.
    Kim MJ; Kim SN; Lee IS; Chung S; Lee J; Yang Y; Lee I; Koh SE
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1343-50. PubMed ID: 26214607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating osteoporosis: economic aspects of bisphosphonate therapy.
    Kennedy CC; Papaioannou A; Adachi JD
    Expert Opin Pharmacother; 2006 Aug; 7(11):1457-67. PubMed ID: 16859429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Teriparatide and bisphosphonate use in osteoporotic spinal fusion patients: a systematic review and meta-analysis.
    Tsai SHL; Chien RS; Lichter K; Alharthy R; Alvi MA; Goyal A; Bydon M; Fu TS; Lin TY
    Arch Osteoporos; 2020 Oct; 15(1):158. PubMed ID: 33030619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bisphosphonate therapy for children and adolescents with secondary osteoporosis.
    Ward L; Tricco AC; Phuong P; Cranney A; Barrowman N; Gaboury I; Rauch F; Tugwell P; Moher D
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD005324. PubMed ID: 17943849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study.
    Conway SP; Oldroyd B; Morton A; Truscott JG; Peckham DG
    Thorax; 2004 Aug; 59(8):699-703. PubMed ID: 15282392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
    Chen L; Wang G; Zheng F; Zhao H; Li H
    Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of bone disease in cystic fibrosis.
    Aris R; Lester G; Ontjes D
    Curr Opin Pulm Med; 2004 Nov; 10(6):524-30. PubMed ID: 15510061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of bisphosphonates in pediatrics.
    Baroncelli GI; Bertelloni S
    Horm Res Paediatr; 2014; 82(5):290-302. PubMed ID: 25376487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical review 1: Bisphosphonate use in childhood osteoporosis.
    Bachrach LK; Ward LM
    J Clin Endocrinol Metab; 2009 Feb; 94(2):400-9. PubMed ID: 19033370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy and safety of bisphosphonates for osteoporosis or osteopenia in Crohn's disease: a meta-analysis.
    Guo Z; Wu R; Gong J; Zhu W; Li Y; Li N; Li J
    Dig Dis Sci; 2013 Apr; 58(4):915-22. PubMed ID: 23179146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New bisphosphonates for the treatment of osteoporosis: concerns and hopes.
    Reginster JY
    Rev Rhum Engl Ed; 1996; 63(7-8):461-4. PubMed ID: 8896057
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bisphosphonates in osteoporosis. Recommendations can not replace the clinical assessment].
    Wallander M; Palmér M; Lorentzon M
    Lakartidningen; 2016 Apr; 113():. PubMed ID: 27070393
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis.
    Jiang L; Dong J; Wei J; Liu L
    BMC Musculoskelet Disord; 2022 Nov; 23(1):1027. PubMed ID: 36447169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases.
    Cowan S; Morin S; Ernst P
    Thorax; 1998 May; 53(5):331-2. PubMed ID: 9708219
    [No Abstract]   [Full Text] [Related]  

  • 38. Implant treatment in patients with osteoporosis.
    Mellado-Valero A; Ferrer-García JC; Calvo-Catalá J; Labaig-Rueda C
    Med Oral Patol Oral Cir Bucal; 2010 Jan; 15(1):e52-7. PubMed ID: 19767691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonate use in children with pediatric osteoporosis and other bone conditions.
    Szalay EA
    J Pediatr Rehabil Med; 2014; 7(2):125-32. PubMed ID: 25096864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonates for steroid-induced osteoporosis.
    Allen CS; Yeung JH; Vandermeer B; Homik J
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD001347. PubMed ID: 27706804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.